Physician profile
Stacy L Fish
NPI 1598063851
$3,620.98
in general payments reported to CMS, 2019-2025
20 companies · $1,342 in 2025
The $1,342 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,231 · 2023: $526 · 2024: $522 · 2025: $1,342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,823 · Consulting Fee: $500 · Gift: $66.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,823.08 |
| Consulting Fee | $500.00 |
| Gift | $66.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,310.60 | 2022-2025 | Interstim |
| Abbvie INC. | $1,031.00 | 2022-2025 | |
| Accord Healthcare, INC. | $158.45 | 2023-2025 | |
| Janssen Biotech, INC. | $149.40 | 2022-2025 | Erleada, Akeega |
| Pfizer INC. | $126.47 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $110.38 | 2023-2025 | Keytruda, Lynparza |
| Sumitomo Pharma America, INC. | $109.06 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $107.76 | 2023-2025 | Myrbetriq, Veozah |
| Dendreon Pharmaceuticals LLC | $89.40 | 2023-2025 | Provenge |
| Endo USA, INC. | $71.92 | 2025 | Xiaflex, Aveed |
| Bayer Healthcare Pharmaceuticals INC. | $63.28 | 2022-2023 | |
| Endo Pharmaceuticals INC. | $58.40 | 2022-2023 | Xiaflex, Aveed |
| Olympus America INC. | $47.40 | 2025 | Itind System |
| Amgen INC. | $44.55 | 2022 | |
| Bluewind Medical | $39.31 | 2025 | Revi |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Medicine, INC. | $28.49 | 2022-2023 | |
| Alnylam Pharmaceuticals INC. | $20.15 | 2023 | Oxlumo |
| Bioprotect Medical, INC. | $18.94 | 2025 | Bioprotect Balloon Implant System |
| Immunitybio, INC. | $18.14 | 2025 | |
| Urogen Pharma, INC. | $17.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Fish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.